Therma Bright (TSE:THRM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Therma Bright Inc. celebrates the successful initial clinical trial results of the PREVA™ ischemic stroke device, developed by its investment partner Inretio, which were presented at the BRAIN Conference 2024. The device promises to revolutionize stroke care by improving patient recovery outcomes, marking a significant milestone for Inretio’s clinical program.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.